Federation des caisses Desjardins du Quebec’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-40	Closed	-$7.08K	–	2623
2021 Q3	$7.08K	Buy	+40	New	+$6.43K	﹤0.01%	2148
2020 Q1	–	Sell	-40	Closed	-$5.15K	–	2392
2019 Q4	$5.15K	Hold	40	–	–	﹤0.01%	2016
2019 Q3	$3.12K	Hold	40	–	–	﹤0.01%	2041
2019 Q2	$4.12K	Hold	40	–	–	﹤0.01%	2029
2019 Q1	$2.93K	Hold	40	–	–	﹤0.01%	1885
2018 Q4	$1.7K	Buy	+40	New	+$1.59K	﹤0.01%	1926

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's MRTX Position: Q4 2021 in Review

Federation des caisses Desjardins du Quebec sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q4 2021, closing a stake of 40 shares — an estimated $7.08K sold.

Federation des caisses Desjardins du Quebec first reported a position in MRTX in Q4 2018 and held it in 6 quarters. The position peaked at $7.08K in Q3 2021. 260 funds tracked by Wall St. Rank hold MRTX as of Q4 2021.

Federation des caisses Desjardins du Quebec reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 40 Mirati Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $7.08K.
Federation des caisses Desjardins du Quebec first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2018 and held it in 6 quarters.
Federation des caisses Desjardins du Quebec's Mirati Therapeutics, Inc. Common Stock position peaked at $7.08K in Q3 2021.
260 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2021, filed 30 Aug 2024.